GURU.Markets stock price, segment price, and overall market index valuation
The company's share price BioNexus Gene Lab Corp.
Shares of BioNexus Gene Lab, a biotech company, are extremely volatile. Their price reflects speculative hopes for a breakthrough in its scientific research rather than fundamentals.
Share prices of companies in the market segment - Chemistry
BioNexus Gene Lab is a company that develops and sells genetic tests and analyses, as well as distributes chemical reagents. We've classified it in the "Chemistry" category. The chart below shows how investors value companies at the intersection of biotechnology and chemicals.
Broad Market Index - GURU.Markets
BioNexus Gene Lab is a company that specializes in developing and selling blood-based tests for disease detection and monitoring. Its focus on diagnostics makes it a prominent player in the GURU.Markets index. The chart below represents the entire market. Find out how BioNexus compares to it.
Change in the price of a company, segment, and market as a whole per day
BGLC - Daily change in the company's share price BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp.'s daily share price fluctuations reflect the volatility of the biotech sector. This metric measures the sensitivity to demand for its blood testing services and the development of algorithms for early disease diagnosis.
Daily change in the price of a set of shares in a market segment - Chemistry
BioNexus Gene Lab operates in the genetic research industry, where volatility is driven by scientific discoveries. The chart below shows average daily fluctuations in the chemical/biotech sector. This provides a benchmark for assessing BGLC stock's sensitivity to innovation.
Daily change in the price of a broad market stock, index - GURU.Markets
BioNexus Gene Lab is a biotechnology company operating in the fields of medical diagnostics and chemistry. Its shares represent a venture bet on scientific success and the commercialization of new tests. Their high volatility contributes to the dynamics of the overall stock market.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization BioNexus Gene Lab Corp.
For BioNexus Gene Lab Corp., year-over-year performance tells the story of its performance in the genetic testing market. Its market capitalization over the past 12 months reflects its success in delivering its diagnostic services, as well as its ability to adapt to rapid technological change and the intense competition in this complex field of medicine.
Annual dynamics of market capitalization of the market segment - Chemistry
BioNexus, as a private company, likely specializes in niche chemical or biotech products. Its growth depends on innovation and the ability to commercialize its technology. Its valuation dynamics will reflect its success in this area, potentially outperforming the sector due to its flexibility and unique offering.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
BioNexus Gene Lab, a genetic testing provider, is growing at a pace that reflects the demand for personalized medicine. Its ability to stay ahead of the market depends on expanding its range of tests and securing contracts with clinics. This is a bet that the future of medicine lies in genetics.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization BioNexus Gene Lab Corp.
BioNexus Gene Lab provides genetic testing services. Its monthly growth reflects demand for its tests and its ability to expand its market presence. News about the launch of new tests or partnerships with clinics are the main drivers.
Monthly dynamics of market capitalization of the market segment - Chemistry
BioNexus Gene Lab Corp. is a company specializing in the development and sale of genetic tests and the distribution of chemicals. The dynamics of its sector, shown in the chart, serve as background information. It is interesting to assess how its business, which combines diagnostics and chemical distribution, is developing in the Southeast Asian markets.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
BioNexus Gene Lab is a genetic testing company. Its shares move on news about the development and implementation of new tests. The chart will show little correlation with the market, as investors evaluate the scientific and commercial potential of its diagnostic products rather than general economic trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization BioNexus Gene Lab Corp.
BioNexus Gene Lab is a biotechnology company focused on genetic testing. Its weekly stock price reflects demand for its services and its ability to develop and commercialize new tests.
Weekly dynamics of market capitalization of the market segment - Chemistry
BioNexus Gene Lab Corp. operates in the fields of chemical analysis and biotechnology. The chart compares the company's weekly performance with its sector. To what extent does its success in developing new tests and methods allow it to stand out from the general industry trends?
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
BioNexus Gene Lab Corp., as a biotech company, should be less dependent on economic cycles. The chart will show how insulated the company's shares are from general market fluctuations, moving with product and development news while ignoring macroeconomic noise.
Market capitalization of the company, segment and market as a whole
BGLC - Market capitalization of the company BioNexus Gene Lab Corp.
The BioNexus Gene Lab chart reflects the state of the genetic testing market. This company's market cap reflects how investors assess its ability to sell its screening and diagnostic services in emerging markets, where competition and regulation can be unpredictable.
BGLC - Share of the company's market capitalization BioNexus Gene Lab Corp. within the market segment - Chemistry
BioNexus Gene Lab is a company engaged in research and development in the fields of genetics and chemistry. Its share of the chemical or biotech sector's market capitalization reflects its scientific potential. The company's weight is an indicator of investors' confidence in its ability to translate its research into commercially successful products or technologies.
Market capitalization of the market segment - Chemistry
BioNexus Gene Lab operates in chemical and biological research. How big is this industry? The chart below shows the overall market capitalization of the chemical sector. Its dynamics reflect the constant need for innovation and precise analysis across industries, from medicine to food.
Market capitalization of all companies included in a broad market index - GURU.Markets
The BioNexus Gene Lab urban dynamics illustrate how the market values a company operating in genetic testing and natural ingredient development. Its market capitalization is the market's assessment of its ability to monetize its scientific research. This diagram illustrates a business at the intersection of biotech and wellness.
Book value capitalization of the company, segment and market as a whole
BGLC - Book value capitalization of the company BioNexus Gene Lab Corp.
For BioNexus Gene Lab, a genetic testing company, book value is its tangible assets: laboratories, diagnostic equipment, and IT infrastructure for data analysis. The chart below shows how the company has invested in building this scientific and technological platform.
BGLC - Share of the company's book capitalization BioNexus Gene Lab Corp. within the market segment - Chemistry
BioNexus Gene Lab Corp. is a genetic testing company. Its tangible assets are diagnostic labs equipped with sequencers and other high-tech equipment. The chart shows the share of this modern medical infrastructure the company controls in its region.
Market segment balance sheet capitalization - Chemistry
BioNexus Gene Lab is a diagnostics company. Its model is knowledge-intensive in the capital-intensive healthcare sector. The industry's asset chart reflects the value of hospitals. BioNexus, on the other hand, invests in laboratories for genetic testing.
Book value of all companies included in the broad market index - GURU.Markets
BioNexus Gene Lab's assets include laboratories and a distribution network in Malaysia, providing genetic testing services and selling healthcare products. Its book value reflects its scientific and commercial infrastructure in the regional market.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - BioNexus Gene Lab Corp.
BioNexus Gene Lab is a genetic testing company. Its value lies in its laboratory services and data. The chart shows how the market evaluates its position in the competitive genetic testing market.
Market to book capitalization ratio in a market segment - Chemistry
BioNexus Gene Lab Corp. is a genetic testing and health product development company. The chart shows how the market values its technologies and their applications in personalized medicine and wellness compared to its laboratory assets.
Market to book capitalization ratio for the market as a whole
BioNexus Gene Lab offers genetic testing services. The company's value lies in its technology, database, and reputation, not in its lab equipment. This chart shows how the market values companies in the field of personalized medicine, where data and analytical accuracy generate the primary value.
Debts of the company, segment and market as a whole
BGLC - Company debts BioNexus Gene Lab Corp.
BioNexus Gene Lab provides genetic testing services. Laboratory operations require investment in expensive equipment and reagents, as well as marketing to attract customers. This chart illustrates how the company uses borrowed funds to expand its laboratory capacity and range of tests.
Market segment debts - Chemistry
BioNexus Gene Lab is a company focused on genetic testing and product development based on natural ingredients. This business requires investment in laboratory equipment and research. This chart shows how the company funds its operations and development.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp. is a genetic testing company. This chart shows its financial structure. In the rapidly evolving diagnostics market, investing in technology is crucial. High debt can limit this ability and slow the company's growth compared to more agile competitors.
Market segment debt to market segment book capitalization - Chemistry
BioNexus Gene Lab Corp. is engaged in research and development in genetics and biotechnology. This sector requires significant and ongoing investment in science. The chart shows the overall debt burden in the industry, highlighting the financial resources required to conduct fundamental, yet commercially risky, research.
Debt to book value of all companies in the market
BioNexus Gene Lab Corp. is a genetic testing company. This business requires investment in laboratory equipment and technology. This chart provides context for assessing the company's financial policies: how it uses capital to expand its services and how its debt burden compares to other players in the diagnostic services market.
P/E of the company, segment and market as a whole
P/E - BioNexus Gene Lab Corp.
This chart for BioNexus Gene Lab, a genetic testing company, shows its valuation in a competitive market. The price-to-earnings ratio reflects the demand for its services and its ability to compete with larger labs. This is a bet that its tests will be in demand in medical diagnostics.
P/E of the market segment - Chemistry
BioNexus Gene Lab is a company that develops and provides genetic testing and analysis services to identify risks for various diseases. This chart shows the average rating for the chemical industry, which helps understand how the market values this company in the field of personalized medicine.
P/E of the market as a whole
BioNexus Gene Lab is a Malaysian genetic testing company. Its valuation depends on demand for its services in its home markets. While this chart reflects global sentiment, for BioNexus, the specific conditions of the healthcare system and consumer trends in Southeast Asia are much more important.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp. is engaged in the research, development, and sale of diagnostic tests based on genetic information. This chart reflects the expected growth of the personalized medicine market. The company's future profitability depends on demand for its tests and its ability to develop new diagnostic products.
%20P%2FE%20BioNexus%20Gene%20Lab%20Corp.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-BioNexus-Gene-Lab-Corp.&v=1772582340976 "Chart of the company's future (projected) P/E BioNexus Gene Lab Corp.")
Future (projected) P/E of the market segment - Chemistry
BioNexus Gene Lab provides genetic testing services. Its valuation relative to other companies in the medical diagnostics sector reflects investor opinions on its technology and market position. This reflects how the market assesses the demand for genetic testing and its ability to compete in this rapidly growing field.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Chemistry&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Chemistry&v=1772582341056 "Future (projected) P/E graph of the market segment - Chemistry")
Future (projected) P/E of the market as a whole
BioNexus Gene Lab is a genetic testing company, likely based in Southeast Asia. Its business depends on demand for diagnostic tests and the development of personalized medicine. This chart shows the overall sentiment in the healthcare sector, which influences the valuations of companies operating in the growing but competitive field of genetics.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772582341070 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit BioNexus Gene Lab Corp.
BioNexus Gene Lab is a company specializing in the development and sale of genetic testing for disease detection and prevention. The financial results illustrated in this chart depend on demand for its diagnostic services in Southeast Asian markets.
Profit of companies in the market segment - Chemistry
BioNexus Gene Lab Corp. is engaged in chemical and biotech research. This chart reflects overall profitability in the chemical and biotech industries. It helps assess the potential for fundamental research and the development of new compounds to be transformed into profitable businesses over the long term.
Overall market profit
BioNexus Gene Lab provides genetic testing services. Demand for these services is growing due to increased awareness of preventive medicine. This long-term trend is more important for BGLC than short-term economic cycles, although consumers may reduce spending on optional tests during downturns.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company BioNexus Gene Lab Corp.
BioNexus Gene Lab provides genetic testing services. The company's future profitability depends on consumer and medical demand for its tests. This chart reflects analyst expectations for growth in the personalized medicine and genetic diagnostics market.
%20profit%20of%20the%20company%20BioNexus%20Gene%20Lab%20Corp.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-BioNexus-Gene-Lab-Corp.&v=1772582341229 "Graph of future (projected) profit of the company BioNexus Gene Lab Corp.")
Future (predicted) profit of companies in the market segment - Chemistry
BioNexus Gene Lab is a biotechnology research and development company, specifically genetic analysis and testing. This chart shows forecasts for the chemical industry. It helps assess how advances in genomics and personalized medicine are creating new opportunities for companies working with biological data and reagents.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Chemistry&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Chemistry&v=1772582341249 "Graph of future (predicted) profits of companies in a market segment - Chemistry")
Future (predicted) profit of the market as a whole
This chart reflects the investment climate in biotechnology. BioNexus Gene Lab, a genetic research company, depends on the availability of funding. Economic growth and interest in personalized medicine are driving capital inflows. A recession, however, could slow the pace of research.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772582341320 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - BioNexus Gene Lab Corp.
BioNexus Gene Lab provides genetic testing services. This metric reflects how the market values its revenue, which depends on the demand for diagnostic tests and its ability to expand their range.
P/S market segment - Chemistry
BioNexus Gene Lab provides genetic testing and analysis services. This chart shows the average valuation in the chemical and biotech industries. It helps understand how investors view the demand for genetic testing and BioNexus's position in this fast-growing but competitive personalized medicine market.
P/S of the market as a whole
BioNexus Gene Lab Corp. is engaged in the research, development, and sale of diagnostic tests based on genetic data. The company's revenue depends on demand for its tests and services. This chart provides an overview of market sentiment for the company, which operates in the growing but competitive field of genetic diagnostics.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp. is engaged in DNA analysis and diagnostic testing development. Future revenue depends on demand for genetic testing in healthcare and wellness. This chart shows how investors assess the growth of the personalized medicine market and the company's role in it.
%20P%2FS%20BioNexus%20Gene%20Lab%20Corp.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-BioNexus-Gene-Lab-Corp.&v=1772582341461 "The graph of the company's future (projected) P/S BioNexus Gene Lab Corp.")
Future (projected) P/S of the market segment - Chemistry
BioNexus Gene Lab is a biotechnology company focused on testing and research in genetics and molecular diagnostics. It may offer disease screening services or test development. This chart shows how the market estimates its future revenue in the chemical and genetic analysis sector.
%20P%2FS%20market%20segment%20graph%20-%20Chemistry&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Chemistry&v=1772582341584 "Future (projected) P/S market segment graph - Chemistry")
Future (projected) P/S of the market as a whole
This chart shows general expectations for the genetic diagnostics market. For BioNexus Gene Lab, a company developing genetic tests, this indicates a trend toward personalized medicine. Market optimism is fueling demand for tests that can aid in early diagnosis and disease prevention.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772582341634 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales BioNexus Gene Lab Corp.
BioNexus Gene Lab is a Malaysian company providing DNA testing services for disease predisposition and other wellness purposes. This chart shows revenue from genetic testing. Revenue growth reflects growing consumer interest in personalized medicine and genetic information.
Sales of companies in the market segment - Chemistry
BioNexus Gene Lab Corp. is engaged in research and development in the fields of genetics and chemistry. This graph illustrates the overall dynamics of the chemical and biotech industries. The company likely provides testing services or develops new products at the intersection of these two sciences, reflecting the convergence of technologies in modern science.
Overall market sales
BioNexus Gene Lab Corp. is a genetic testing and research company. Demand for its services is growing as personalized medicine advances. The overall economic situation, shown in this chart, impacts healthcare costs and the willingness of consumers and clinics to pay for advanced diagnostic tests.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company BioNexus Gene Lab Corp.
BioNexus Gene Lab is a biotechnology research and development company that distributes chemical reagents and tests. This chart reflects analysts' expectations for growing demand for its products and services in the scientific and medical communities.
%20sales%20of%20the%20company%20BioNexus%20Gene%20Lab%20Corp.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-BioNexus-Gene-Lab-Corp.&v=1772582341832 "Schedule of future (projected) sales of the company BioNexus Gene Lab Corp.")
Future (projected) sales of companies in the market segment - Chemistry
BioNexus Gene Lab provides genetic testing services. This chart shows expectations for the chemical and biotech industries. It reflects the growing interest in personalized medicine and genetics, which is the main driver of demand for the company's services.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Chemistry&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Chemistry&v=1772582341852 "Schedule of future (projected) sales of companies in the market segment - Chemistry")
Future (projected) sales of the market as a whole
BioNexus Gene Lab Corp. develops and markets diagnostic tests based on genetic analysis. Demand for its products is driven by the trend toward personalized and preventive medicine. This chart, reflecting overall healthcare spending, demonstrates the willingness of consumers and healthcare systems to invest in early disease detection.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772582341924 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality BioNexus Gene Lab Corp.
BioNexus Gene Lab provides genetic testing services. This chart shows profitability in the field of personalized medicine. The company's profitability depends on the number of tests performed and their cost. The accuracy and speed of analysis are key competitive advantages.
Market segment marginality - Chemistry
BioNexus Gene Lab Corp. specializes in genetic testing and biopharmaceutical development. Profitability in this business depends on test accuracy, reagent costs, and demand from medical institutions. This chart shows the average profitability in the sector, allowing one to assess how effectively the company operates in its niche.
Market marginality as a whole
BioNexus Gene Lab is a company specializing in genetic testing and product development based on natural ingredients. This total economic return chart reflects purchasing power. Demand for its services and products depends on consumers' willingness to spend money on personalized medicine and a healthy lifestyle.
Employees in the company, segment and market as a whole
Number of employees in the company BioNexus Gene Lab Corp.
BioNexus Gene Lab is a Malaysian company developing and marketing blood-based tests for the early diagnosis of diseases. This graphic shows the small team of scientists and lab technicians behind this technology.
Share of the company's employees BioNexus Gene Lab Corp. within the market segment - Chemistry
BioNexus Gene Lab Corp. is engaged in chemical research and analysis. This chart shows the percentage of chemists, laboratory technicians, and genetic analysis specialists the company employs in its niche. It reflects its scientific potential and the operational capabilities of its laboratories, which are the core of its business.
Number of employees in the market segment - Chemistry
BioNexus Gene Lab is a company focused on genetic testing and research. Genome sequencing opens new possibilities for personalized medicine. This graph shows how genomics is becoming a major industry, requiring laboratory technicians, geneticists, bioinformaticians, and consultants to conduct and interpret tests.
Number of employees in the market as a whole
BioNexus Gene Lab Corp. works in the field of genetic research. The sequencing of the genome ushered in a new era in medicine and biology. This graph shows today's job market, but it is in labs like BioNexus's that the foundation is being laid for future breakthroughs that will create entirely new professions and industries.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company BioNexus Gene Lab Corp. (BGLC)
BioNexus Gene Lab is a company focused on genetic testing and supplement development. This chart reflects the value of its intellectual capital. Its key assets are testing technology, data, and product formulas. The chart shows how highly the market values these knowledge-intensive assets and their market potential per lab or R&D employee.
%20of%20the%20company%20BioNexus%20Gene%20Lab%20Corp.%20(BGLC)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-BioNexus-Gene-Lab-Corp.-BGLC&v=1772582342594 "Chart of market capitalization per employee (in thousands of dollars) of the company BioNexus Gene Lab Corp. (BGLC)")
Market capitalization per employee (in thousands of dollars) in the market segment - Chemistry
BioNexus Gene Lab Corp. operates in the field of genetic testing. In this rapidly developing field, technological accuracy and data processing speed are crucial. This chart shows how the market values their technology platform and team of specialists. This is an indicator of their competitiveness in the genetic services market.
%20by%20market%20segment%20-%20Chemistry&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Chemistry&v=1772582342620 "Market capitalization per employee (in thousands of dollars) by market segment - Chemistry")
Market capitalization per employee (in thousands of dollars) for the overall market
BioNexus Gene Lab Corp. is a company that develops and sells diagnostic tests. This chart shows the overall market productivity assessment, which helps evaluate the research-intensive business in the healthcare sector.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772582342654 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company BioNexus Gene Lab Corp. (BGLC)
BioNexus Gene Lab is a genetic testing company. It's a healthcare service business. This chart shows how efficiently their labs operate. It reflects the net profit each technician and scientist generates from testing.
%20Chart%20BioNexus%20Gene%20Lab%20Corp.%20(BGLC)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-BioNexus-Gene-Lab-Corp.-BGLC&v=1772582342704 "Company Profit Per Employee (in thousands of dollars) Chart BioNexus Gene Lab Corp. (BGLC)")
Profit per employee (in thousands of dollars) in the market segment - Chemistry
BioNexus Gene Lab Corp. develops and markets genetic screening tests. It is a company at the intersection of biotechnology and diagnostics. This chart shows how successfully the commercial team brings its products to market, and the financial return per employee is an indicator of market demand and the company's operational efficiency.
%20in%20the%20market%20segment%20-%20Chemistry&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Chemistry&v=1772582342719 "Chart of profit per employee (in thousands of dollars) in the market segment - Chemistry")
Profit per employee (in thousands of dollars) for the market as a whole
BioNexus Gene Lab (BGLC) is a Malaysian company engaged in R&D, manufacturing, and distribution of wellness products (dietary supplements) and health screening (genetic tests). This chart shows the average profit per employee (for the US). It helps investors understand how BGLC's R&D and distribution in Asia compares in labor efficiency to the US market average.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772582342752 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee BioNexus Gene Lab Corp. (BGLC)
BioNexus Gene Lab provides genetic testing services. This chart reflects its performance in the personalized medicine sector. It shows how successfully the company's laboratory performs tests and delivers results to clients, generating revenue from each test performed.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-BioNexus-Gene-Lab-Corp.-BGLC&v=1772582342841 "Sales chart per company employee BioNexus Gene Lab Corp. (BGLC)")
Sales per employee in the market segment - Chemistry
BioNexus Gene Lab is a company providing genetic testing services, primarily in Southeast Asia. It's a diagnostics business. This chart shows the average revenue per employee in this segment. It helps evaluate how productive BioNexus's lab and commercial team are compared to other diagnostics companies.
Sales per employee for the market as a whole
BioNexus Gene Lab is a Malaysian company providing genetic testing and analysis services. It's a B2C/B2B service business. This chart shows how productive their lab technicians and sales staff are, generating revenue from the sale and processing of DNA tests.
Short shares by company, segment and market as a whole
Shares shorted by company BioNexus Gene Lab Corp. (BGLC)
BioNexus Gene Lab is a Malaysian (ADR) company engaged in genetic testing and dietary supplement development. It's a highly opaque "micro-cap." This chart shows the bets that it's a sham. "Bearers" doubt the validity of their tests, the effectiveness of their dietary supplements, and the credibility of their financial statements.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-BioNexus-Gene-Lab-Corp.-BGLC&v=1772582343096 "Short Shares Chart for the Company BioNexus Gene Lab Corp. (BGLC)")
Shares shorted by market segment - Chemistry
BioNexus Gene Lab Corp. is a DNA analysis company providing genetic testing services in Southeast Asia. This chart shows the overall bearish sentiment in the chemicals and diagnostics sector. The rising price may reflect investor doubts about the profitability or accuracy of genetic testing in this region.
Shares shorted by the overall market
BioNexus Gene Lab is a Malaysian company operating in genetic testing and analysis. This chart measures overall fear. When investors are pessimistic, they avoid illiquid microcaps from emerging markets. Geopolitical and currency risks, combined with general market fear, make BGLC shares an easy target for sell-offs.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator BioNexus Gene Lab Corp. (BGLC)
BioNexus Gene Lab is a company providing genetic testing (DNA) services in Asia. The genomics market is growing rapidly, but it is also competitive. This indicator shows when investors are "overbought" (above 70) on growth expectations or "oversold" (below 30) amid price wars.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-BioNexus-Gene-Lab-Corp.-BGLC&v=1772582343229 "RSI 14 indicator chart for the company's stock BioNexus Gene Lab Corp. (BGLC)")
RSI 14 Market Segment - Chemistry
BioNexus Gene Lab is a Malaysian company providing genetic testing and analysis services for disease risk identification. This chart measures the overall "temperature" in the specialty chemicals and diagnostics sector. It helps understand whether the entire segment is overheating amid growing demand for personalized medicine.
RSI 14 for the overall market
For BioNexus Gene Lab, a biotech company in R&D, this chart is a lifeline showing capital availability. During periods of market euphoria, investors are willing to "buy the dream" and fund breakthrough but risky research. When the market panics, the money supply is shut off, and cash-burning companies face a liquidity crisis.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast BGLC (BioNexus Gene Lab Corp.)
BioNexus Gene Lab provides genomic testing and DNA analysis services. This chart shows the average analyst forecast. Their goals are based on increasing testing volumes, launching new diagnostic panels, and expanding into new geographic markets, particularly in Asia.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-BGLC-BioNexus-Gene-Lab-Corp.&v=1772582343339 "A chart showing analyst consensus forecasts for the expected stock price. BGLC (BioNexus Gene Lab Corp.)")
The difference between the consensus estimate and the actual stock price BGLC (BioNexus Gene Lab Corp.)
BioNexus Gene Lab is a Malaysian company providing genetic testing services (DNA testing) in Southeast Asia. This chart illustrates the analyst community's opinion on the company's future. It measures the distance between the stock price and the target, reflecting their outlook on the growth of the personalized medicine market in the region.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-BGLC-BioNexus-Gene-Lab-Corp.&v=1772582343405 "A chart showing the difference between the consensus forecast and the actual stock price. BGLC (BioNexus Gene Lab Corp.)")
Analyst consensus forecast for stock prices by market segment - Chemistry
BioNexus Gene Lab is a Malaysian company providing genetic testing services (DNA tests) for disease risk assessment and personalized wellness. This chart shows the general expectations of analysts for the chemical sector (and diagnostics). It reflects whether experts believe the D2C genetics market in Asia will grow.
Analysts' consensus forecast for the overall market share price
BioNexus Gene Lab (BGLC) is likely a micro-cap Asian biotech company focused on genetic testing or R&D. It is a highly speculative asset. This chart shows the overall risk appetite in the market. It reflects how willing investors are to invest in opaque and volatile micro-caps.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index BioNexus Gene Lab Corp.
BioNexus Gene Lab is a Malaysian biotech services company. They provide genetic testing (screening) and distribution (sales) of chemicals and laboratory equipment in Southeast Asia. This chart summarizes their service model, reflecting their testing volumes and margins in the competitive biotech services market.
AKIMA Market Segment Index - Chemistry
BioNexus Gene Lab (BGLC) is a Malaysian company specializing in preventive medicine. They provide blood testing and genomic testing to identify disease risks. This chart shows the average index for the segment. It helps investors assess how this diagnostics and wellness model compares to the average in the chemical/biotech industry.
The AKIM Index for the overall market
BioNexus Gene Lab is a Malaysian company engaged in molecular diagnostics and chemical raw material trading. This chart, showing the average (global/US) market value, serves as a benchmark. It helps assess how BGLC, a niche player in Asia, compares to overall macroeconomic trends.
